Back
Curis 10K Form
Sell
20
CRIS
Curis
Last Price:
$1.78
Seasonality Move:
-5.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | CRIS/Curis Quarterly |
| 2023-11-02 | 10Q | CRIS/Curis Quarterly |
| 2023-08-03 | 10Q | CRIS/Curis Quarterly |
| 2023-05-04 | 10Q | CRIS/Curis Quarterly |
| 2022-11-09 | 10Q | CRIS/Curis Quarterly |
| 2022-08-04 | 10Q | CRIS/Curis Quarterly |
Receive CRIS News And Ratings
See the #1 stock for the next 7 days that we like better than CRIS
CRIS Financial Statistics
Sales & Book Value
| Annual Sales: | $10.9M |
|---|---|
| Cash Flow: | $-7.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.63 |
| Price / Book: | 9.96 |
Profitability
| EPS (TTM): | -6.23000 |
|---|---|
| Net Income (TTM): | $-42.1M |
| Gross Margin: | $10.8M |
| Return on Equity: | -461.34% |
| Return on Assets: | -89.45% |
Curis Earnings Forecast
Key Curis Financial Ratios
-
The Gross Profit Margin over the past 25 years for CRIS is 99.10%.
-
The Selling, General & Administrative Expenses for CRIS have been equal to 153.92% of Gross Profit Margin.
-
The Research & Development expenses have been 353.52% of Revenue.
-
The Net Earning history of CRIS is -397.77% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 17 years.
Curis Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CRIS |
| CUSIP: | 231269 |
| Website: | curis.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.23 |
| Quick Ratio: | 1.12 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |